Mirum Pharmaceuticals CEO Christopher Peetz reports sale of $1.8 million in common shares

PUBT · 1d ago
Mirum Pharmaceuticals CEO Christopher Peetz reports sale of $1.8 million in common shares
  • Mirum Pharmaceuticals CEO and director Christopher Peetz sold 20,000 common shares at $90 each on November 4, 2026.
  • Peetz exercised employee stock options for 20,000 common shares at $2.936 each that day.
  • Following the transactions, he held 206,637 common shares directly and 187,500 indirectly through The Peetz Family Trust.
  • Remaining employee stock options totaled 38,487, with a March 11, 2029 expiration date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001614740-26-000015), on November 04, 2026, and is solely responsible for the information contained therein.